GlassScriptPhysician profile
Christopher Michael Hart
NPI 1518390467
$8,448.69
in general payments reported to CMS, 2019-2025
7 companies · $457 in 2025
The $457 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $22.50 · 2023: $2,936 · 2024: $5,033 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,108 · Education: $2,404 · Travel and Lodging: $2,263 · Grant: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,108.46 |
| Education | $2,404.42 |
| Travel and Lodging | $2,263.31 |
| Grant | $650.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,750.56 | 2022-2025 | Tornier Perform Reversed Glenoid, Blueprint Patient Specific Instrumentation, Aequalis Perform |
| Zimmer Biomet Holdings, INC. | $286.87 | 2024 | Comprehensive Shoulder System, Identity |
| Globus Medical, INC. | $153.98 | 2023 | Evo Retrograde |
| Arthrex, INC. | $134.55 | 2024-2025 | |
| Smith+Nephew, INC. | $93.48 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Mf Med | $14.79 | 2025 | |
| Atricure, INC. | $14.46 | 2025 | Synergy Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.